Abstract
At present, there are no specific nationwide epidemiological studies representing the whole Italian population. This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. This analysis was developed for the period 2012-2030 from the perspective of the Italian National Health Service (NHS).
Lingua originale | English |
---|---|
pagine (da-a) | 303-310 |
Numero di pagine | 8 |
Rivista | ClinicoEconomics and Outcomes Research |
Volume | 6 |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- chronic hepatitis
- cost of illness
- forecast
- new HCV treatment